乾照光电 reported revenue of ¥0.89B for the period ended 2026-06-30, -48.9% year on year. Net income was ¥0.09B, a 10.2% net margin on a 19.4% gross margin. The largest revenue line is 外延片及芯片 at 97% of the total. Free cash flow for the period was ¥0.06B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.89B | -48.9% |
| Gross profit | ¥0.17B | — |
| Operating income | ¥0.08B | — |
| Net income | ¥0.09B | +30.6% |
| Gross margin | 19.4% | Net margin 10.2% |
| Revenue Q/Q | +17.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 外延片及芯片 | ¥0.87B | 97.4% |
| 其他 | ¥0.02B | 2.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.72B | 80.6% |
| R&D | ¥0.07B | 8.3% |
| SG&A | ¥0.08B | 8.6% |
| Tax & other | ¥-0.01B | -0.9% |
| Item | Amount |
|---|---|
| Total assets | ¥6.50B |
| Total liabilities | ¥2.13B |
| Shareholders' equity | ¥4.37B |
| Equity / assets | 67.2% |
| Operating cash flow | ¥0.10B |
| Capital expenditure | ¥0.03B |
| Free cash flow | ¥0.06B |
| Cash conversion (OCF / net income) | 37% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
达刚控股 ・ 龙源技术 ・ 西部牧业 ・ 建新股份 ・ 新开源 ・ 华仁药业 ・ 向日葵 ・ 万讯自控 ・ 顺网科技 ・ 长盈精密 ・ 东方日升 ・ 瑞普生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies